National Institutes of Health criticised for not preventing conflicts of interestBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7456.10-b (Published 01 July 2004) Cite this as: BMJ 2004;329:10
- Janice Hopkins Tanne
- New York
The US National Institutes of Health (NIH) has been criticised by members of Congress for letting employees accept lucrative consultancy assignments from drug and biotechnology companies.
On 22 June the director of the NIH, Dr Elias Zerhouni, told the House Energy and Commerce Oversight and Investigations Subcommittee, “In retrospect, there was not a sufficient safeguard against the perception of conflict of interest.” He said the NIH would tighten rules about employees' consultancy work.
The NIH's troubles began on 7 December 2003. …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial